In a 72-year-old man with Parkinson disease who is sleeping well on 25 mg trazodone but has persistent anxiety and depression and developed intolerable side effects after one week of sertraline, what is the appropriate next step in management?

Discontinue Sertraline and Switch to Mirtazapine

Given the intolerable side effects from sertraline after one week, discontinue it immediately and switch to mirtazapine 7.5-15 mg at bedtime, which will address both the depression/anxiety and complement the existing trazodone for sleep. This approach leverages a well-tolerated antidepressant with a different mechanism that has documented efficacy in Parkinson's disease while avoiding the side effects that made sertraline intolerable.

Rationale for This Approach

Why Discontinue Sertraline Now

The FDA label for sertraline clearly warns about serious side effects including serotonin syndrome, manic episodes, and worsening agitation—particularly problematic in elderly patients with Parkinson's disease 1. After one week of intolerable side effects, continuing sertraline risks:

• Serotonin syndrome when combined with trazodone (both are serotonergic agents) 1
• Worsening motor symptoms in Parkinson's disease, as SSRIs have isolated case reports of motor deterioration 2
• Poor adherence leading to treatment failure

The evidence shows SSRIs like sertraline can be effective in PD depression 3, 4, but tolerability is paramount in a 72-year-old already on trazodone.

Why Mirtazapine is the Optimal Choice

Mirtazapine addresses multiple needs simultaneously:

1. Depression and anxiety treatment: Consensus guidelines specifically recommend mirtazapine as a sedating antidepressant for comorbid depression/anxiety 5. Recent expert consensus identifies mirtazapine as efficacious and well-tolerated for depression in Parkinson's disease 3.

2. Complementary to existing trazodone: Both are sedating, but mirtazapine works through different mechanisms (alpha-2 antagonist, antihistamine) rather than serotonin reuptake inhibition, reducing serotonin syndrome risk while enhancing sleep quality 6.

3. Favorable side effect profile in elderly: The 2009 geriatric sleep guidelines note mirtazapine's efficacy with acceptable tolerability 7. The 2016 palliative care guidelines recommend mirtazapine 7.5-30 mg at bedtime for insomnia 8.

4. Parkinson's-specific benefits: Expert consensus from neurologists, psychiatrists, and geriatrists specifically endorses mirtazapine for PD-related depression 3. It lacks the motor worsening concerns of SSRIs and has minimal anticholinergic effects compared to tricyclics 6.

Specific Dosing Algorithm

Start mirtazapine 7.5 mg at bedtime (can use half of a 15 mg tablet):

• This low dose maximizes sedation through antihistamine effects
• Increase to 15 mg after 1 week if depression/anxiety persist
• Can titrate up to 30 mg if needed after 2-4 weeks
• Lower doses (7.5-15 mg) are often sufficient when combined with trazodone 25 mg

Continue trazodone 25 mg at bedtime:

• It's working well for sleep—don't disrupt this success
• The combination is safe and commonly used 9
• Trazodone also has anxiolytic properties that complement mirtazapine

Alternative Considerations if Mirtazapine Fails

If mirtazapine causes intolerable side effects (mainly sedation or weight gain):

Second-line: Venlafaxine 37.5 mg daily

• SNRI with strong evidence in PD depression 10, 3
• Expert consensus supports venlafaxine and desvenlafaxine 3
• Monitor blood pressure (can increase it) 10
• Start low due to age and titrate slowly

Third-line: Nortriptyline 10-25 mg at bedtime

• Tricyclic with evidence in PD depression 10
• Fewer anticholinergic effects than amitriptyline 6
• Therapeutic blood levels helpful (50-150 ng/mL) 6
• Avoid if significant orthostatic hypotension or cognitive impairment

Avoid entirely:

• Other SSRIs (citalopram, paroxetine)—same class as sertraline that failed 3, 4
• Tricyclics with high anticholinergic burden (amitriptyline)—worsen cognition and motor symptoms 6, 10
• MAO-B inhibitor combinations with serotonergic drugs—serotonin syndrome risk 10, 3

Critical Safety Considerations

Watch for serotonin syndrome during transition:

• Sertraline has a 26-hour half-life; takes ~5 days to clear
• Can start mirtazapine immediately (different mechanism reduces risk)
• Monitor for agitation, confusion, tremor, tachycardia, fever 1

Monitor for falls:

• Both trazodone and mirtazapine are sedating
• Parkinson's patients have baseline fall risk
• Counsel on taking medications only at bedtime, not getting up quickly 7

Reassess in 2 weeks:

• Evaluate tolerability and early response
• Adjust dose based on depression/anxiety symptoms
• Consider adding cognitive behavioral therapy if available 11, 12

This approach prioritizes safety, leverages existing successful sleep treatment, and uses evidence-based pharmacotherapy specifically validated in elderly Parkinson's patients with depression and anxiety.